Table: begin end state 1 62 non-cytoplasmic 63 83 transmembrane 84 93 cytoplasmic 94 113 transmembrane 114 118 non-cytoplasmic 119 140 transmembrane 141 163 cytoplasmic 164 184 transmembrane 185 194 non-cytoplasmic 195 214 transmembrane 215 250 cytoplasmic 251 270 transmembrane 271 289 non-cytoplasmic 290 310 transmembrane 311 318 cytoplasmic 319 338 transmembrane 339 344 non-cytoplasmic 345 368 transmembrane 369 378 cytoplasmic 379 401 transmembrane 402 412 non-cytoplasmic 413 432 transmembrane 433 445 cytoplasmic
Input: >WP_057507967.1 NCBI__GCF_001431535.1:WP_057507967.1 MSISQSTAASPVSERAALKRSVSNTLKGSAGNLVEWYDVYVYSVFAKYFESQFFSADDKN STMYIWGIFAATFLMRPIGAWYFGRFADRYGRRLALTVSVSVMAACSFLIAIAPTAASIG IWAAVILLFARLLQGFATGGEYGASATYMSEAAVPGWRGFLSSFHYVTLVGGHVLAQAVL LVMLLSWDTSHVSEWGWRVAFGIGGIGALVVFWLRRTMDESLSAESIEAAKDGKAKASGS MRELFVNQWRPLLLCFLITAGGTVAFYTYTINGPKMIQTAFAGDDVITGTWINLGVLTFL MLLQPLGGLLSDRIGRKSLLVFFGVGGVLYTWYLVTALPQQTSALSAFLILATGFVILTG YTSINAVVKAELFPAHIRALGVGLGYALANSLFGGTAPLLYQGALKAGRVDEFVIYITAV IAVSLVVYIFFLKNKGPNWLDGTRK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server